Brought to you by 
Series D leads to $20mm for OmniSonics
21 Jun 2007
Executive Summary
OmniSonics Medical Technologies (treatments for vascular occlusive conditions) brought in $20mm through its Series D financing to returning shareholders Canaan Partners, Domain Associates, Johnson & Johnson Development Corp., Nomura Phase4 Ventures, New England Partners, and H&Q Capital Management. The company hopes to raise an additional $15mm in the round from outside investors. OmniSonics' plans to use the funds to file for 510k approval of its OmniWave ultrasonic technology for breaking up blood clots and for product launch later this year.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series D leads to $20mm for OmniSonics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice